Adaptive immunity, particularly tumor-reactive CD8+ T cells with support from Th1-polarized CD4+ T cells, can restrain outgrowth by continuous immune pressure and cytokine-mediated enforcement of non-progression [126,143]. The gene discussed is CD8A; the disease is neoplasm.